| Wednesday, August 31, 2011 |
| 12:00 PM - 01:00 PM Eastern Daylight Time |
Morgan Lewis and Merrill DataSite invite you to an engaging discussion on what can happen when business development deals go wrong, how to spot a potential breach of license, and what to do when litigation is imminent.
Morgan Lewis Litigation partners will share their experiences from a recently won licensing case with antitrust overtones. After a three-month trial, a California state court jury ordered Actelion Ltd. to pay Asahi Kasei Pharma Corp. $550 million in damages for interrupting an Asahi licensing agreement to develop hypertension drug Fasudil.
Presenters:
Rollin Chippey
Partner, Morgan Lewis
Benjamin Smith
Partner, Morgan Lewis
David Yeary
Vice President, Merrill DataSite